MCID: ALC002
MIFTS: 16

Alcohol-Related Neurodevelopmental Disorder malady

Categories: Fetal diseases, Neuronal diseases

Aliases & Classifications for Alcohol-Related Neurodevelopmental Disorder

About this section

Aliases & Descriptions for Alcohol-Related Neurodevelopmental Disorder:

Name: Alcohol-Related Neurodevelopmental Disorder 10 12
Static Encephalopathy 10 65
 
Alcohol Related Neurodevelopmental Disorder 65
Arnd 10

Classifications:



External Ids:

Disease Ontology10 DOID:0050667
UMLS65 C0814154, C3662068

Summaries for Alcohol-Related Neurodevelopmental Disorder

About this section
Disease Ontology:10 A fetal alcohol spectrum disorder that results in central nervous system dysfunction and behavioral and/or cognitive deficits due to prenatal alcohol exposure.

MalaCards based summary: Alcohol-Related Neurodevelopmental Disorder, also known as static encephalopathy, is related to neurodegeneration with brain iron accululation 5 and fetal alcohol spectrum disorder. An important gene associated with Alcohol-Related Neurodevelopmental Disorder is PFAS (Phosphoribosylformylglycinamidine Synthase).

Related Diseases for Alcohol-Related Neurodevelopmental Disorder

About this section

Graphical network of diseases related to Alcohol-Related Neurodevelopmental Disorder:



Diseases related to alcohol-related neurodevelopmental disorder

Symptoms for Alcohol-Related Neurodevelopmental Disorder

About this section

Drugs & Therapeutics for Alcohol-Related Neurodevelopmental Disorder

About this section

Drugs for Alcohol-Related Neurodevelopmental Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 30)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DopamineapprovedPhase 4308462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
2
Methylphenidateapproved, investigationalPhase 4364113-45-14158
Synonyms:
.alpha.-Phenyl-2-piperidineacetic acid methyl ester
113-45-1
2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester
2-Piperidineacetic acid, alpha-phenyl-, methyl ester
298-59-9 (hydrochloride)
4311/B Ciba
AC1L1HJM
C 4311
C07196
CHEBI:6887
CHEMBL796
CID4158
Calocain
Centedein
Centedrin
Centedrine
Centredin
Concerta
D-Methylphenidate HCl
D04999
DB00422
DB06701
DEA No. 1724
Daytrana
Daytrana (TN)
EINECS 204-028-6
Focalin
Focalin XR
HSDB 3126
L001307
LS-565
METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R)
MPH
Meridil
Metadate
Metadate CD
Metadate ER
MethyPatch
Methyl (2-phenyl-2-(2-piperidyl)acetate)
Methyl alpha-phenyl-alpha-(2-piperidyl)acetate
Methyl alpha-phenyl-alpha-2-piperidinylacetate
Methyl phenidate
Methyl phenidyl acetate
 
Methyl phenidylacetate
Methylfenidan
Methylin
Methylin ER
Methylofenidan
Methylphen
Methylphenidan
Methylphenidate
Methylphenidate (USAN/INN)
Methylphenidate HCl
Methylphenidate Hydrochloride
Methylphenidate [INN:BAN]
Methylphenidate hydrochloride
Methylphenidatum
Methylphenidatum [INN-Latin]
Methylphenidylacetate hydrochloride
Methypatch
Metilfenidat hydrochloride
Metilfenidato
Metilfenidato [INN-Spanish]
Metilfenidato [Italian]
MolPort-001-779-620
NCI-C56280
PMS-Methylphenidate
Phenidylate
Plimasine
Quillivant XR
Riphenidate
Ritalin
Ritalin LA
Ritalin SR
Ritalin hydrochloride
Ritalin-SR
Ritaline
Ritcher Works
Ritcher works
Tsentedrin
UNII-207ZZ9QZ49
alpha-Phenyl-2-piperidineacetic acid methyl ester
alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester
d-methylphenidate HCl
methyl 2-phenyl-2-piperidin-2-ylacetate
methyl phenyl(piperidin-2-yl)acetate
methylphenidate
nchembio.2007.55-comp28
3Neurotransmitter Uptake InhibitorsPhase 4, Phase 32857
4Central Nervous System StimulantsPhase 41721
5Dopamine AgentsPhase 43084
6Neurotransmitter AgentsPhase 4, Phase 314795
7Dopamine Uptake InhibitorsPhase 4925
8Phase 3, Phase 2, Phase 1
9Neuroprotective AgentsPhase 2, Phase 31376
10
Epigallocatechin gallatePhase 2, Phase 356989-51-565064
Synonyms:
(-)-Epigallocatechin gallat
(-)-Epigallocatechin gallate
(-)-Epigallocatechin-3-O-gallate
(-)-Epigallocatechol gallate
(-)-Epigallocatehin gallate
Catechin deriv.
 
EGCG
Epigallocatcchin Gallate
Epigallocate
Epigallocatechin 3-gallate
Epigallocatechin Gallate
Epigallocic acid
Galloyl-L-epigallocatechol
Tea catechin
11Protective AgentsPhase 2, Phase 35651
12Atomoxetine HydrochloridePhase 3160
13Adrenergic AgentsPhase 34204
14AntioxidantsPhase 2, Phase 32442
15Epigallocatechinexperimental, NutraceuticalPhase 2, Phase 3519882981
16
Cholineapproved, nutraceuticalPhase 2, Phase 113062-49-7305
Synonyms:
(2-Hydroxyethyl)trimethyl ammonium
(2-Hydroxyethyl)trimethylammonium
(beta-hydroxyethyl)trimethylammonium
2-Hydroxy-N,N,N-trimethyl-ethanaminium
2-Hydroxy-N,N,N-trimethylethanaminium
Bilineurine
Biocolina
Biocoline
Choline
Choline cation
 
Choline ion
Cholinum
Hepacholine
Hormocline
Lipotril
N,N,N-Trimethylethanol-ammonium
N,N,N-Trimethylethanolammonium
N,N,N-trimethylethanol-ammonium
N-trimethylethanolamine
Neocolina
Paresan
trimethylethanolamine
17
GlycerolexperimentalPhase 219156-81-5753
Synonyms:
1,2,3-Trihydroxypropane
Bulbold
Cristal
E 422
Emery 916
Glyceol Opthalgan
Glycerin
Glycerine
Glyceritol
Glycerol
 
Glycyl alcohol
Glyrol
Glysanin
IFP
Incorporation factor
Mackstat H 66
Osmoglyn
Pricerine 9091
Propanetriol
RG-S
Trihydroxypropane
Tryhydroxypropane
18Hypolipidemic AgentsPhase 2, Phase 12228
19Nootropic AgentsPhase 2, Phase 1604
20Gastrointestinal AgentsPhase 2, Phase 16401
21AntimetabolitesPhase 2, Phase 19454
22
Naltrexoneapproved, investigational34916590-41-35360515
Synonyms:
16590-41-3
16676-29-2
17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-6-one
BIDD:GT0405
BPBio1_000146
BRD-K88172511-310-03-8
BRN 3596648
BSPBio_000132
C07253
CCRIS 3506
CHEBI:121459
CHEBI:7465
CHEMBL142
CID5360515
Celupan
D05113
DB00704
Depade
EINECS 240-649-9
EN-1639A
HMS2089O11
HS-0002
HSDB 6750
LS-92094
MLS002153483
MolPort-004-920-221
MorViva
 
N-Cyclopropylmethyl-14-hydroxydihydromorphinone
N-Cyclopropylmethylnoroxymorphone
Naltrexon
Naltrexona
Naltrexona [INN-Spanish]
Naltrexone
Naltrexone (USAN/INN)
Naltrexone Hcl
Naltrexone Hydrochloride
Naltrexone [USAN:BAN:INN]
Naltrexone [USAN:INN:BAN]
Naltrexone [Usan:Ban:Inn]
Naltrexonum
Naltrexonum [INN-Latin]
PDSP2_000847
PTI-555
Prestwick0_000116
Prestwick1_000116
Prestwick2_000116
Prestwick3_000116
ReVia
Revia
SMP1_000206
SPBio_002071
UM-792
UNII-5S6W795CQM
Vivitrex
Vivitrol
Vivitrol (TN)
naltrexone
naltrexone (ReVia)
23Narcotic Antagonists814
24Peripheral Nervous System Agents18510
25Narcotics2709
26Detox adjuvant23
27Anti-Infective Agents17220
28Anti-Infective Agents, Local984
29Central Nervous System Depressants10016
30Contraceptives, Oral3734

Interventional clinical trials:

(show all 16)
idNameStatusNCT IDPhase
1Treatment of Patients With Alcoholism and Attention Deficit DisorderCompletedNCT00261872Phase 4
2Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHDRecruitingNCT00418262Phase 3
3Epigallocatechin Gallate (EGCG) to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) ChildrenRecruitingNCT02558933Phase 2, Phase 3
4Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHDActive, not recruitingNCT00417794Phase 3
5Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND)CompletedNCT00164346Phase 1, Phase 2
6Choline Supplementation in Children With Fetal Alcohol Spectrum DisordersCompletedNCT01911299Phase 2
7Postnatal Choline Supplementation in Children With Prenatal Alcohol ExposureCompletedNCT01149538Phase 1, Phase 2
8Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum DisordersNot yet recruitingNCT02735473Phase 2
9Expansion to Interdisciplinary HIV Prevention in WomenCompletedNCT01994603
10Development of Education Materials for Prevention of FAS in RussiaCompletedNCT01971398
11Preventing FAS/ARND in Russian ChildrenCompletedNCT01961050
12Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)CompletedNCT00579267
13Parenting Training for Children With FASDRecruitingNCT02210455
14ADHD: Gaps Between Patients With Alcohol-dependence and Impact on RelapseRecruitingNCT02364817
15Control of CognitionRecruitingNCT01993108
16Does Delaying Adolescent Substance Use Lead to Improved Cognitive Function and Reduce Risk for Addiction?Active, not recruitingNCT01655615

Search NIH Clinical Center for Alcohol-Related Neurodevelopmental Disorder

Genetic Tests for Alcohol-Related Neurodevelopmental Disorder

About this section

Anatomical Context for Alcohol-Related Neurodevelopmental Disorder

About this section

Animal Models for Alcohol-Related Neurodevelopmental Disorder or affiliated genes

About this section

Publications for Alcohol-Related Neurodevelopmental Disorder

About this section

Articles related to Alcohol-Related Neurodevelopmental Disorder:

idTitleAuthorsYear
1
Mucosal Integrity Factors Are Perturbed during Bacterial Vaginosis: A Proteomic Analysis. (25357822)
2014
2
Pathogenesis of middle ear cholesteatoma: a new model of experimentally induced cholesteatoma in Mongolian gerbils. (20413684)
2010
3
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. (15788542)
2005
4
Expression of osteopontin in cisplatin-induced tubular injury. (15292680)
2004
5
Cancrum oris (noma) in a patient with acute lymphoblastic leukaemia. A complication of chemotherapy induced neutropenia. (9619095)
1998
6
Effect of human biliary immunoglobulins on the nucleation of cholesterol. (8444895)
1993
7
Familial syringomyelia. (4045487)
1985

Variations for Alcohol-Related Neurodevelopmental Disorder

About this section

Expression for genes affiliated with Alcohol-Related Neurodevelopmental Disorder

About this section
Search GEO for disease gene expression data for Alcohol-Related Neurodevelopmental Disorder.

Pathways for genes affiliated with Alcohol-Related Neurodevelopmental Disorder

About this section

GO Terms for genes affiliated with Alcohol-Related Neurodevelopmental Disorder

About this section

Sources for Alcohol-Related Neurodevelopmental Disorder

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet